AU2645692A - Composition comprising s-oxiracetame for use as nootropic - Google Patents

Composition comprising s-oxiracetame for use as nootropic

Info

Publication number
AU2645692A
AU2645692A AU26456/92A AU2645692A AU2645692A AU 2645692 A AU2645692 A AU 2645692A AU 26456/92 A AU26456/92 A AU 26456/92A AU 2645692 A AU2645692 A AU 2645692A AU 2645692 A AU2645692 A AU 2645692A
Authority
AU
Australia
Prior art keywords
oxiracetame
nootropic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26456/92A
Inventor
Laura Chiodini
Giancarlo Pepeu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline SpA
Original Assignee
Smithkline Beecham Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Farmaceutici SpA filed Critical Smithkline Beecham Farmaceutici SpA
Publication of AU2645692A publication Critical patent/AU2645692A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU26456/92A 1991-10-08 1992-10-03 Composition comprising s-oxiracetame for use as nootropic Abandoned AU2645692A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919121289A GB9121289D0 (en) 1991-10-08 1991-10-08 Composition and use
GB9121289 1991-10-08

Publications (1)

Publication Number Publication Date
AU2645692A true AU2645692A (en) 1993-05-03

Family

ID=10702556

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26456/92A Abandoned AU2645692A (en) 1991-10-08 1992-10-03 Composition comprising s-oxiracetame for use as nootropic

Country Status (4)

Country Link
EP (1) EP0607201A1 (en)
AU (1) AU2645692A (en)
GB (1) GB9121289D0 (en)
WO (1) WO1993006826A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3614366B2 (en) 1998-07-24 2005-01-26 サムスン ファイン ケミカルズ カンパニー リミテッド Process for producing optically pure (S) -3,4-dihydroxybutyric acid derivative
US6713290B2 (en) 1998-07-24 2004-03-30 Samsung Fine Chemicals Co., Ltd. Process for preparing optically pure (S)-3-hydroxy-γ-butyrolactone
CN104173336B (en) * 2010-03-31 2018-02-02 重庆润泽医药有限公司 Application of the levo-oxiracetam in prevention or treatment cognition dysfunction medicine is prepared
CN102204904B (en) * 2010-03-31 2014-10-01 重庆润泽医药有限公司 Application of levorotatory oxiracetamto preparation of medicaments for preventing or treating cognitive dysfunction
CN102249974B (en) * 2010-05-21 2014-10-15 重庆润泽医药有限公司 Preparation method of (s)-4-hydroxy-2-oxo-1-pyrrolidineacetamide
CN102558013B (en) 2011-08-11 2013-12-18 重庆润泽医药有限公司 (S)-4-hydroxy-2-oxo-1-pyrrolidine acetamide crystal form II and preparation method thereof
CN102531988A (en) 2011-08-11 2012-07-04 重庆润泽医疗器械有限公司 Purification method for sinistrogyration oxiracetam
CN102531989B (en) 2011-08-11 2014-02-05 重庆润泽医药有限公司 Purification method for (S)-oxiracetam
CN102600130A (en) * 2012-03-26 2012-07-25 北京阜康仁生物制药科技有限公司 New clinical use of oxiracetam and optical isomer of oxiracetam
CN102670497A (en) * 2012-05-31 2012-09-19 北京阜康仁生物制药科技有限公司 Stable S-oxiracetam preparation for injection and preparation method of same
CN103553998B (en) * 2013-11-06 2015-11-25 温州智创科技有限公司 (S) preparation method of-Oxiracetam crystal form III
CN103553997B (en) * 2013-11-06 2015-11-25 温州智创科技有限公司 The preparation method of a kind of (S)-Oxiracetam crystal form III
CN103554000B (en) 2013-11-06 2015-03-11 重庆润泽医药有限公司 (S)-oxiracetam crystal form III, and preparation method and application thereof
CN103599101A (en) * 2013-11-08 2014-02-26 南京优科生物医药研究有限公司 Application of levo-oxiracetam in preparation of medicine for treating memory and intelligence disturbance
KR20170137910A (en) * 2015-05-18 2017-12-13 충칭 룬즈 파마슈티컬 컴퍼니 리미티드. Application of R-oxylacetam in pharmaceutical field
CN106511311A (en) * 2015-09-11 2017-03-22 重庆润泽医药有限公司 Levo-oxiracetam sustained-release capsule with good particle mobility and preparation method of levo-oxiracetam sustained-release capsule
CN106511305A (en) * 2015-09-11 2017-03-22 重庆润泽医药有限公司 L-oxiracetam slow release capsule with high yield and preparation method thereof
CN106511306B (en) * 2015-09-11 2020-08-11 重庆润泽医药有限公司 Levo-oxiracetam sustained-release capsule and preparation method thereof
CN106606485A (en) * 2015-10-27 2017-05-03 重庆润泽医药有限公司 Good taste levo S-oxiracetam particle and preparation method thereof
CN106619529A (en) * 2015-10-27 2017-05-10 重庆润泽医药有限公司 Levorotatory oxiracetam granule with good content uniformity and preparation method thereof
CN106619525A (en) * 2015-10-27 2017-05-10 重庆润泽医药有限公司 (S)-4-hydroxy-2-oxo-1-pyrrolidine acetamide particles having uniform content, and preparation method thereof
CN106822058B (en) * 2015-12-07 2020-08-11 重庆润泽医药有限公司 Levo-oxiracetam oral dispersion film agent and preparation method thereof
CN107115272B (en) * 2016-02-25 2020-08-11 重庆润泽医药有限公司 Levo-oxiracetam injection with few impurities and preparation method thereof
CN105853473B (en) * 2016-03-31 2019-12-13 海南合瑞制药股份有限公司 oxiracetam pharmaceutical composition and preparation method thereof
CN107281121B (en) * 2016-03-31 2020-10-09 重庆润泽医药有限公司 (S) -4-hydroxy-2 oxo-1-pyrrolidine acetamide freeze-dried powder for injection and preparation method thereof
CN107281135B (en) * 2016-03-31 2020-09-29 重庆润泽医药有限公司 Levo-oxiracetam freeze-dried powder for injection and preparation method thereof
CN107397722B (en) * 2016-05-20 2020-08-11 重庆润泽医药有限公司 (S) -4-hydroxy-2-oxo-1-pyrrolidine acetamide freeze-dried powder for injection and preparation method thereof
CN107432861B (en) * 2016-05-26 2020-08-11 重庆润泽医药有限公司 Levo-oxiracetam freeze-dried composition for injection and preparation method thereof
CN107510665A (en) * 2016-06-15 2017-12-26 重庆润泽医药有限公司 Good levo-oxiracetam particle of a kind of content uniformity and preparation method thereof
CN107510656A (en) * 2016-06-15 2017-12-26 重庆润泽医药有限公司 Good oxo-1-pyrrolidine ethanamide particle of (S) -4- hydroxyls -2 of a kind of stability and preparation method thereof
CN107625747A (en) * 2016-07-13 2018-01-26 重庆润泽医药有限公司 Pyrrolidine acetamide spansule of 2 oxo of a kind of (S) 4 hydroxyl 1 and preparation method thereof
CN107661315A (en) * 2016-07-28 2018-02-06 重庆润泽医药有限公司 A kind of levo-oxiracetam capsule for being sustained release and preparation method thereof
CN107661314A (en) * 2016-07-28 2018-02-06 重庆润泽医药有限公司 A kind of stability is good（S）Pyrrolidine acetamide spansule of 4 hydroxyl, 2 oxo 1 and preparation method thereof
CN114621128A (en) * 2022-03-10 2022-06-14 成都百途医药科技有限公司 Preparation method of (S) -oxiracetam

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1075280B (en) * 1977-02-11 1985-04-22 Isf Spa PROCEDURE FOR THE PREPARATION OF PYROLIDINE DERIVATIVES

Also Published As

Publication number Publication date
GB9121289D0 (en) 1991-11-20
EP0607201A1 (en) 1994-07-27
WO1993006826A1 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
AU2645692A (en) Composition comprising s-oxiracetame for use as nootropic
AU2212192A (en) Cosmetic composition
AU2092892A (en) Polyolefin composition
AU2963192A (en) Fullerene-polymer compositions
AU3201593A (en) Cosmetic composition
AU2822892A (en) Oxygen-scavenging composition
AU1829992A (en) Cosmetic composition
AU5794094A (en) Tricritical point composition
AU4498093A (en) Ink compositions
AU3683993A (en) Cosmetic composition
AU3181393A (en) Cosmetic composition
AU2128992A (en) Carbon fluoride compositions
AU7703091A (en) Stabilized fgf composition
AU1037792A (en) Plaster composition
AU1009892A (en) Homogenous ink composition
AU4509993A (en) Composition for use as a food or food supplement
AU1013992A (en) Lice-repellant compositions
AU2888292A (en) Toiletries composition
AU3029992A (en) Cosmetic composition
AU7437094A (en) Disinfectant-detergent composition
AU2960892A (en) Immunogen composition
AU2818792A (en) Cosmetic composition
AU1093992A (en) Cosmetic composition
AU1090692A (en) Antiperspirant composition
AU5773994A (en) Cable-making compositions